About Microbial Identification
Microbial Identification is a company based in Newark (United States) founded in 1991 was acquired by Biolog in January 2023. Microbial Identification operates in a competitive market with competitors including Insitro, DNAnexus, HotSpot Therapeutics, TOLREMO therapeutics and Certara, among others.
- Headquarter Newark, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Microbial Identification
Investors in Microbial Identification
Microbial Identification has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Biolog.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Cell-based phenotyping technologies and assays are provided for microbial analysis.
|
Locked | Locked | Locked |
Investor details for Microbial Identification
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Microbial Identification
Investment portfolio details for Microbial Identification
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Microbial Identification
Detailed financials for Microbial Identification
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Microbial Identification Comparisons
Peer comparison for Microbial Identification
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Microbial Identification
Microbial Identification operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, DNAnexus, HotSpot Therapeutics, TOLREMO therapeutics and Certara, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Cloud-based genome informatics and data management are provided.
|
|
| Locked | Locked | Locked |
Developer of a platform for protein function analysis
|
|
| Locked | Locked | Locked |
Anti-cancer small molecules are developed to target drug resistance pathways.
|
|
| Locked | Locked | Locked |
Provider of a platform for in silico drug discovery and consulting services
|
|
| Locked | Locked | Locked |
Developer of predictive informatics based platform for drug discovery
|
Detailed competitors of Microbial Identification
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Microbial Identification
Complete news archive for Microbial Identification
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Microbial Identification
Microbial Identification was founded in 1991 and raised its 1st funding round 17 years after it was founded.
Microbial Identification is headquartered in Newark, United States. It is registered at Newark, New Jersey, United States.
Microbial Identification Inc (MIDI) offers chemical data analysis and pattern recognition solutions. Products include Sherlock Microbial Identification System (MIS) - solution for the identification of over 1,500 microbial species, fatty acids and PLFAs by GC-FAME analysis; Sherlock PLFA Method and Tools Package (PLFAD1) which names over 150 PLFAs and related compounds and can be used for fatty acid analysis; Sherlock Mycobacteria Identification System (MYCO-LCS) - solution for the identification of Mycobacterium tuberculosis and 60 other mycobacteria and related species that produce mycolic acids; DNA sequencing software; and X Fire Debris Analysis Software solution. microbial Identification Inc (MIDI) group provides solutions for food, forensics,agriculture, pharmaceutical, biotech, and public health. Products include Sherlock Microbial Identification System for the identification of over 1,500 microbial species, fatty acids and PLFAs by GC-FAME analysis, Phospholipid Fatty Acid Analysis (PLFA) system, Mycobacteria Identification System (MYCO-LCS) for the identification of Mycobacterium tuberculosis Sherlock DNA Sequencing software and fire debris analysis solution which combines Sherlock X software and methods with an Agilent GC-MS and Agilent ChemStation analysis software.
Microbial Identification's top competitors include Insitro, DNAnexus and HotSpot Therapeutics.